SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-119546
Filing Date
2023-11-17
Accepted
2023-11-17 16:36:05
Documents
14
Period of Report
2023-11-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2331053d1_8k.htm   iXBRL 8-K 32603
2 EXHIBIT 99.1 tm2331053d1_ex99-1.htm EX-99.1 15534
3 GRAPHIC tm2331053d1_img001.jpg GRAPHIC 2465
  Complete submission text file 0001104659-23-119546.txt   230720

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvax-20231113.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20231113_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20231113_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2331053d1_8k_htm.xml XML 3206
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 231419368
SIC: 2836 Biological Products, (No Diagnostic Substances)